By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.
CHOOSE YOUR LANGUAGE
CHOOSE YOUR LANGUAGE
互联网新闻信息许可证10120180008
Disinformation report hotline: 010-85061466
China has been continuously improving its business environment to boost the vitality of foreign companies. In a recent memorandum of understanding, French pharmaceutical giant Sanofi signed an investment worth close to one billion euros (about $1.05 billion) with Beijing, the largest investment in the area in the past decade. CGTN's Cao Bing sat down with Sanofi Global Director and Chairman Frédéric Oudéa to find out what led to such a significant investment.